Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 124

1.

Modeling the durability of ZOSTAVAX® vaccine efficacy in people ≥60 years of age.

Li X, Zhang JH, Betts RF, Morrison VA, Xu R, Itzler RF, Acosta CJ, Dasbach EJ, Pellissier JM, Johnson GR, Chan IS.

Vaccine. 2015 Mar 17;33(12):1499-505. doi: 10.1016/j.vaccine.2014.10.039. Epub 2014 Nov 6.

PMID:
25444784
2.

Varicella-zoster virus-specific antibody responses in 50-59-year-old recipients of zoster vaccine.

Levin MJ, Schmader KE, Gnann JW, McNeil SA, Vesikari T, Betts RF, Keay S, Stek JE, Bundick ND, Su SC, Zhao Y, Li X, Chan IS, Annunziato PW, Parrino J.

J Infect Dis. 2013 Nov 1;208(9):1386-90. doi: 10.1093/infdis/jit342. Epub 2013 Aug 1.

3.

Safety and immunogenicity of heat-treated zoster vaccine (ZVHT) in immunocompromised adults.

Mullane KM, Winston DJ, Wertheim MS, Betts RF, Poretz DM, Camacho LH, Pergam SA, Mullane MR, Stek JE, Sterling TM, Zhao Y, Manoff SB, Annunziato PW.

J Infect Dis. 2013 Nov 1;208(9):1375-85. doi: 10.1093/infdis/jit344. Epub 2013 Aug 1.

PMID:
23908479
4.

Safety of zoster vaccine in elderly adults following documented herpes zoster.

Morrison VA, Oxman MN, Levin MJ, Schmader KE, Guatelli JC, Betts RF, Gelb LD, Pachucki CT, Keay SK, Menzies B, Griffin MR, Kauffman CA, Marques AR, Toney JF, Simberkoff MS, Serrao R, Arbeit RD, Gnann JW, Greenberg RN, Holodniy M, Keitel WA, Yeh SS, Davis LE, Crawford GE, Neuzil KM, Johnson GR, Zhang JH, Harbecke R, Chan IS, Keller PM, Williams HM, Boardman KD, Silber JL, Annunziato PW; Shingles Prevention Study Group.

J Infect Dis. 2013 Aug 15;208(4):559-63. doi: 10.1093/infdis/jit182. Epub 2013 Apr 30.

5.

Outbreak of Mycobacterium chelonae infection associated with tattoo ink.

Kennedy BS, Bedard B, Younge M, Tuttle D, Ammerman E, Ricci J, Doniger AS, Escuyer VE, Mitchell K, Noble-Wang JA, O'Connell HA, Lanier WA, Katz LM, Betts RF, Mercurio MG, Scott GA, Lewis MA, Goldgeier MH.

N Engl J Med. 2012 Sep 13;367(11):1020-4. doi: 10.1056/NEJMoa1205114. Epub 2012 Aug 22.

6.

Efficacy, safety, and tolerability of herpes zoster vaccine in persons aged 50-59 years.

Schmader KE, Levin MJ, Gnann JW Jr, McNeil SA, Vesikari T, Betts RF, Keay S, Stek JE, Bundick ND, Su SC, Zhao Y, Li X, Chan IS, Annunziato PW, Parrino J.

Clin Infect Dis. 2012 Apr;54(7):922-8. doi: 10.1093/cid/cir970. Epub 2012 Jan 30.

7.

The immunogenicity and safety of different formulations of a novel Staphylococcus aureus vaccine (V710): results of two Phase I studies.

Harro CD, Betts RF, Hartzel JS, Onorato MT, Lipka J, Smugar SS, Kartsonis NA.

Vaccine. 2012 Feb 21;30(9):1729-36. doi: 10.1016/j.vaccine.2011.12.045. Epub 2011 Dec 20.

PMID:
22192849
8.

Early removal of central venous catheter in patients with candidemia does not improve outcome: analysis of 842 patients from 2 randomized clinical trials.

Nucci M, Anaissie E, Betts RF, Dupont BF, Wu C, Buell DN, Kovanda L, Lortholary O.

Clin Infect Dis. 2010 Aug 1;51(3):295-303. doi: 10.1086/653935.

PMID:
20578829
9.

A Multicenter, double-blind trial of a high-dose caspofungin treatment regimen versus a standard caspofungin treatment regimen for adult patients with invasive candidiasis.

Betts RF, Nucci M, Talwar D, Gareca M, Queiroz-Telles F, Bedimo RJ, Herbrecht R, Ruiz-Palacios G, Young JA, Baddley JW, Strohmaier KM, Tucker KA, Taylor AF, Kartsonis NA; Caspofungin High-Dose Study Group.

Clin Infect Dis. 2009 Jun 15;48(12):1676-84. doi: 10.1086/598933.

PMID:
19419331
10.

A randomized, placebo-controlled trial of oxycodone and of gabapentin for acute pain in herpes zoster.

Dworkin RH, Barbano RL, Tyring SK, Betts RF, McDermott MP, Pennella-Vaughan J, Bennett GJ, Berber E, Gnann JW, Irvine C, Kamp C, Kieburtz K, Max MB, Schmader KE.

Pain. 2009 Apr;142(3):209-17. doi: 10.1016/j.pain.2008.12.022. Epub 2009 Feb 4.

PMID:
19195785
11.

Vaccination strategies for the prevention of herpes zoster and postherpetic neuralgia.

Betts RF.

J Am Acad Dermatol. 2007 Dec;57(6 Suppl):S143-7.

PMID:
18021866
12.

Micafungin versus caspofungin for treatment of candidemia and other forms of invasive candidiasis.

Pappas PG, Rotstein CM, Betts RF, Nucci M, Talwar D, De Waele JJ, Vazquez JA, Dupont BF, Horn DL, Ostrosky-Zeichner L, Reboli AC, Suh B, Digumarti R, Wu C, Kovanda LL, Arnold LJ, Buell DN.

Clin Infect Dis. 2007 Oct 1;45(7):883-93. Epub 2007 Aug 29. Erratum in: Clin Infect Dis. 2008 Jul 15;47(2):302.

PMID:
17806055
13.

Recommendations for the management of herpes zoster.

Dworkin RH, Johnson RW, Breuer J, Gnann JW, Levin MJ, Backonja M, Betts RF, Gershon AA, Haanpaa ML, McKendrick MW, Nurmikko TJ, Oaklander AL, Oxman MN, Pavan-Langston D, Petersen KL, Rowbotham MC, Schmader KE, Stacey BR, Tyring SK, van Wijck AJ, Wallace MS, Wassilew SW, Whitley RJ.

Clin Infect Dis. 2007 Jan 1;44 Suppl 1:S1-26. Review.

PMID:
17143845
14.

A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults.

Oxman MN, Levin MJ, Johnson GR, Schmader KE, Straus SE, Gelb LD, Arbeit RD, Simberkoff MS, Gershon AA, Davis LE, Weinberg A, Boardman KD, Williams HM, Zhang JH, Peduzzi PN, Beisel CE, Morrison VA, Guatelli JC, Brooks PA, Kauffman CA, Pachucki CT, Neuzil KM, Betts RF, Wright PF, Griffin MR, Brunell P, Soto NE, Marques AR, Keay SK, Goodman RP, Cotton DJ, Gnann JW Jr, Loutit J, Holodniy M, Keitel WA, Crawford GE, Yeh SS, Lobo Z, Toney JF, Greenberg RN, Keller PM, Harbecke R, Hayward AR, Irwin MR, Kyriakides TC, Chan CY, Chan IS, Wang WW, Annunziato PW, Silber JL; Shingles Prevention Study Group.

N Engl J Med. 2005 Jun 2;352(22):2271-84.

15.

Persistent culture-positive Legionella infection in an immunocompromised host.

O'Reilly KM, Urban MA, Barriero T, Betts RF, Trawick DR.

Clin Infect Dis. 2005 May 15;40(10):e87-9. Epub 2005 Apr 1.

PMID:
15844057
16.

Experimental infection of humans with A2 respiratory syncytial virus.

Lee FE, Walsh EE, Falsey AR, Betts RF, Treanor JJ.

Antiviral Res. 2004 Sep;63(3):191-6.

PMID:
15451187
17.

Approaches to improved influenza vaccination.

Betts RF, Treanor JJ.

Vaccine. 2000 Feb 25;18(16):1690-5.

PMID:
10689150
19.

Use of the oral neuraminidase inhibitor oseltamivir in experimental human influenza: randomized controlled trials for prevention and treatment.

Hayden FG, Treanor JJ, Fritz RS, Lobo M, Betts RF, Miller M, Kinnersley N, Mills RG, Ward P, Straus SE.

JAMA. 1999 Oct 6;282(13):1240-6.

PMID:
10517426
20.
21.

Mycobacterium bovis osteomyelitis involving a hip arthroplasty after intravesicular bacille Calmette-Guérin for bladder cancer.

Guerra CE, Betts RF, O'Keefe RJ, Shilling JW.

Clin Infect Dis. 1998 Sep;27(3):639-40.

PMID:
9770167
22.
23.
24.

Failure of cefotaxime treatment in an adult with Streptococcus pneumoniae meningitis.

Pacheco TR, Cooper CK, Hardy DJ, Betts RF, Bonnez W.

Am J Med. 1997 Mar;102(3):303-5. Review. No abstract available.

PMID:
9217602
25.

Recombinant baculovirus influenza A hemagglutinin vaccines are well tolerated and immunogenic in healthy adults.

Lakey DL, Treanor JJ, Betts RF, Smith GE, Thompson J, Sannella E, Reed G, Wilkinson BE, Wright PF.

J Infect Dis. 1996 Oct;174(4):838-41.

PMID:
8843225
26.

Evaluation of a recombinant hemagglutinin expressed in insect cells as an influenza vaccine in young and elderly adults.

Treanor JJ, Betts RF, Smith GE, Anderson EL, Hackett CS, Wilkinson BE, Belshe RB, Powers DC.

J Infect Dis. 1996 Jun;173(6):1467-70.

PMID:
8648221
27.

Safety and efficacy of the neuraminidase inhibitor GG167 in experimental human influenza.

Hayden FG, Treanor JJ, Betts RF, Lobo M, Esinhart JD, Hussey EK.

JAMA. 1996 Jan 24-31;275(4):295-9.

PMID:
8544269
28.

Vaccines in the prevention of viral pneumonia.

Betts RF.

Semin Respir Infect. 1995 Dec;10(4):282-7. Review.

PMID:
8668856
29.

Respiratory syncytial virus and influenza A infections in the hospitalized elderly.

Falsey AR, Cunningham CK, Barker WH, Kouides RW, Yuen JB, Menegus M, Weiner LB, Bonville CA, Betts RF.

J Infect Dis. 1995 Aug;172(2):389-94.

PMID:
7622882
30.

Communitywide laboratory-based influenza surveillance focused on older persons, 1989-1992.

Barker WH, Menegus MA, Hall CB, Betts RF, Freundlich CB, Long CE, O'Brien DH, Weiner LB, Cunningham C, Bonville CA, et al.

Am J Prev Med. 1995 May-Jun;11(3):149-55.

PMID:
7662393
31.

Oral LY217896 for prevention of experimental influenza A virus infection and illness in humans.

Hayden FG, Tunkel AR, Treanor JJ, Betts RF, Allerheiligen S, Harris J.

Antimicrob Agents Chemother. 1994 May;38(5):1178-81.

32.
33.

Pneumocystis carinii pneumonia associated with concurrent cryptococcosis or toxoplasmosis in patients with AIDS.

Yinnon AM, Betts RF.

Clin Infect Dis. 1994 Jan;18(1):113-4. No abstract available.

PMID:
8054420
34.
35.

Acquired immunodeficiency syndrome-related visceral leishmaniasis presenting in a pleural effusion.

Chenoweth CE, Singal S, Pearson RD, Betts RF, Markovitz DM.

Chest. 1993 Feb;103(2):648-9.

PMID:
8432183
36.

Protective efficacy of combined live intranasal and inactivated influenza A virus vaccines in the elderly.

Treanor JJ, Mattison HR, Dumyati G, Yinnon A, Erb S, O'Brien D, Dolin R, Betts RF.

Ann Intern Med. 1992 Oct 15;117(8):625-33.

PMID:
1530193
37.

Detection of influenza A and B in respiratory secretions with the polymerase chain reaction.

Donofrio JC, Coonrod JD, Davidson JN, Betts RF.

PCR Methods Appl. 1992 May;1(4):263-8.

38.

Viral respiratory infections in the institutionalized elderly: clinical and epidemiologic findings.

Falsey AR, Treanor JJ, Betts RF, Walsh EE.

J Am Geriatr Soc. 1992 Feb;40(2):115-9.

PMID:
1740594
39.

Antiviral agents in respiratory infections.

Betts RF.

Semin Respir Infect. 1991 Sep;6(3):147-57. Review.

PMID:
1754735
40.

Serologic evidence of respiratory syncytial virus infection in nursing home patients.

Falsey AR, Walsh EE, Betts RF.

J Infect Dis. 1990 Aug;162(2):568-9. No abstract available.

PMID:
2197348
41.

Use of live cold-adapted influenza A H1N1 and H3N2 virus vaccines in seropositive adults.

Treanor JJ, Roth FK, Betts RF.

J Clin Microbiol. 1990 Mar;28(3):596-9. Erratum in: J Clin Microbiol 1990 Jun;28(6):1491.

42.

Amantadine and rimantadine for the prevention of influenza A.

Betts RF.

Semin Respir Infect. 1989 Dec;4(4):304-10. Review.

PMID:
2697053
43.
44.

Rimantadine and seizures.

Bentley DW, Karki SD, Betts RF.

Ann Intern Med. 1989 Feb 15;110(4):323-4. No abstract available.

PMID:
2913918
45.

Comparison of live, attenuated H1N1 and H3N2 cold-adapted and avian-human influenza A reassortant viruses and inactivated virus vaccine in adults.

Sears SD, Clements ML, Betts RF, Maassab HF, Murphy BR, Snyder MH.

J Infect Dis. 1988 Dec;158(6):1209-19.

PMID:
3198936
46.
47.

Atypical invasive external otitis from Aspergillus.

Bickley LS, Betts RF, Parkins CW.

Arch Otolaryngol Head Neck Surg. 1988 Sep;114(9):1024-8.

PMID:
3408569
48.

Enzyme-linked immunosorbent assay of core antigens for clinical diagnosis of influenza.

Coonrod JD, Karathanasis P, Betts RF, Donofrio JC.

J Med Virol. 1988 Aug;25(4):399-409.

PMID:
3171556
49.

Four viral genes independently contribute to attenuation of live influenza A/Ann Arbor/6/60 (H2N2) cold-adapted reassortant virus vaccines.

Snyder MH, Betts RF, DeBorde D, Tierney EL, Clements ML, Herrington D, Sears SD, Dolin R, Maassab HF, Murphy BR.

J Virol. 1988 Feb;62(2):488-95.

50.

Intranasally administered interferon as prophylaxis against experimentally induced influenza A virus infection in humans.

Treanor JJ, Betts RF, Erb SM, Roth FK, Dolin R.

J Infect Dis. 1987 Aug;156(2):379-83. No abstract available.

PMID:
3598236

Supplemental Content

Loading ...
Support Center